Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions
Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Jamie L. Hamilton
,
Rebecca L. M. Fuller
,
Noopur Modi
,
Cristina Sampaio
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70138
Similar Items
Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
by: Jeffrey Cummings
Published: (2025)
More fit KL‐VS heterozygotes have more favorable AD‐relevant biomarker profiles
by: Mackenzie Jarchow, et al.
Published: (2025)
Tau biology, biomarkers, and therapeutics
by: Bess Frost, et al.
Published: (2025)
Implications of practice effects for the design of Alzheimer clinical trials
by: Jasmin A. Duehring, et al.
Published: (2025)
The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD
by: Richard Mohs, et al.
Published: (2024)